News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Articles|March 1, 2002

Journal Club

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

FDA approves first generic rifapentine for tuberculosis treatment, prevention in 12 years and older

FDA approves first generic rifapentine for tuberculosis treatment, prevention in 12 years and older

ByMorgan Ebert, Executive Editor

June 23rd 2026

New guideline updates care for central precocious puberty | Image Credit: © Vitalii Vodolazskyi- stock.adobe.com.

New guideline updates care for central precocious puberty

ByMorgan Ebert, Executive Editor

June 23rd 2026

Endocrine-disrupting chemicals detected in breast milk and infant urine through 6 months of age | Image Credit: © geargodz- stock.adobe.com.

Endocrine-disrupting chemicals detected in breast milk and infant urine through 6 months of age

ByMorgan Ebert, Executive Editor

June 23rd 2026

FDA grants priority review to Tivicay PD for neonatal HIV

ByBenjamin P. Saylor

June 22nd 2026

Recent advances in the treatment of molluscum contagiosum | Image Credit: © Hanna - stock.adobe.com.

Recent advances in the treatment of molluscum contagiosum

ByVandita Gorla, BS,Shanna Treanor, MD, MPH

June 22nd 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

Recent advances in the treatment of molluscum contagiosum

FDA approves first generic rifapentine for tuberculosis treatment, prevention in 12 years and older

FDA grants priority review to Tivicay PD for neonatal HIV

Endocrine-disrupting chemicals detected in breast milk and infant urine through 6 months of age

New guideline updates care for central precocious puberty